M7H-19106-99298
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 176 / PA
- Registered
- 2021-06-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-17
Dose 1 — Pfizer-BioNTech
-
2021-06-02
Registered in v-safe
- 2021-06-02
-
2021-06-07
Dose 2 — Pfizer-BioNTech
-
2021-06-07
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Sore at injection site (not an option for an answer above)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-12
- 2021-06-13
- 2021-06-14
- 2021-06-21
- 2021-06-28
- 2021-07-05
- 2021-07-12
- 2021-07-19
- 2021-09-06
- 2021-12-06
- 2022-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-17 | Pfizer-BioNTech | |
| 2 | 2021-06-07 | Pfizer-BioNTech |
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Sore at injection site (not an option for an answer above)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release